Medicare Enrolled

Dr. Umair Ashraf, MD

Pulmonary Disease · Houston, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
6550 FANNIN ST STE 1101, Houston, TX 77030
7134413948
In practice since 2013 (12 years)
NPI: 1487095089 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ashraf from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ashraf? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Ashraf

Dr. Umair Ashraf is a pulmonary disease in Houston, TX, with 12 years in practice. Based on federal Medicare data, Dr. Ashraf performed 1,573 Medicare services across 1,312 unique beneficiaries.

Between the years covered by Open Payments, Dr. Ashraf received a total of $8,933 from 37 pharmaceutical and/or device companies across 195 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Ashraf is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 12 years in practice▲ Top 31% volume in TX$ $8,933 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,573
Medicare services
Top 31% in TX for pulmonary disease
1,312
Unique beneficiaries
$32
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~131 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Test to examine how well the lungs exchange gases283$7$38
Test to determine lung volumes using sensors279$9$51
Hospital follow-up visit, high complexity233$97$302
Test for exercise-induced lung stress210$17$177
Test to measure expiratory airflow and volume199$6$36
Test to measure expiratory airflow and volume changes before and after medication administration167$8$59
Hospital follow-up visit, moderate complexity62$64$211
Office visit, established patient (30-39 min)42$100$314
Initial hospital admission, moderate complexity34$98$401
Office visit, established patient (20-29 min)26$74$212
New patient office visit (45-59 min)23$102$483
Irrigation and suction of lung airways to obtain cells using an endoscope15$109$742
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$8,933
Total received (2018-2024)
Avg $1,276/year across 7 years
Top 22% in TX for pulmonary disease
37
Companies
195
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,933 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,013
2023
$3,511
2022
$364
2021
$515
2020
$190
2019
$2,328
2018
$13

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Covidien LP
$1,893
Medical Device Business Services, Inc.
$1,244
Genentech USA, Inc.
$1,147
Boehringer Ingelheim Pharmaceuticals, Inc.
$868
AstraZeneca Pharmaceuticals LP
$595
United Therapeutics Corporation
$365
Actelion Pharmaceuticals US, Inc.
$362
GlaxoSmithKline, LLC.
$260
Shionogi Inc
$223
Baxter Healthcare
$217
Grifols USA, LLC
$208
Mylan Specialty L.P.
$206
ANI Pharmaceuticals, Inc.
$166
Alexion Pharmaceuticals, Inc.
$125
Body Vision Medical Inc.
$122
Regeneron Healthcare Solutions, Inc.
$105
Insmed, Inc.
$91
ABBVIE INC.
$88
Takeda Pharmaceuticals U.S.A., Inc.
$84
Advanced Respiratory, Inc
$61
Bayer Healthcare Pharmaceuticals Inc.
$57
AbbVie Inc.
$53
Astellas Pharma US Inc
$53
Teva Pharmaceuticals USA, Inc.
$49
GENZYME CORPORATION
$37
Ethicon Inc.
$34
Philips Electronics North America Corporation
$30
Resmed Corp
$28
PFIZER INC.
$27
Mallinckrodt Hospital Products Inc.
$25
Merck Sharp & Dohme LLC
$24
Sandoz Inc.
$22
JAZZ PHARMACEUTICALS INC.
$19
Phadia US Inc.
$15
Merck Sharp & Dohme Corporation
$14
Electromed, Inc.
$12
Inogen, Inc.
$5
Top 3 companies account for 48.0% of total payments
Associated products mentioned in payments ›
(2791) CoughAssist · (8874) inCourage · ACTHAR · AIRSENSE · ARALAST · AREXVY · AVYCAZ · Adempas · AirDuo Digihaler · Arikayce · BEVESPI AEROSPHERE · BREZTRI · Cresemba · DUPIXENT · ELIQUIS · FASENRA · Fetroja · GLASSIA · Hillrom - Life 2000 Ventilation System · Hillrom - Vest System Model 105 Home Care · IMFINZI · ImmunoCAP · InogenOne · LungVision · Monarch Platform · NA · NUCALA · OFEV · OPSUMIT · PURIFIED CORTROPHIN GEL · Prolastin-C Liquid · SMARTVEST · STIOLTO RESPIMAT · SYMBICORT · Strensiq · TAGRISSO · TEFLARO · TEZSPIRE · TRELEGY ELLIPTA · TREPROSTINIL · TYVASO · The Vest System Model 105 Home Care · UPTRAVI · WINREVAIR · XYWAV · YUPELRI · superDimension
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $568 per 100 Medicare services performed
Looking for a pulmonary disease in Houston?
Compare pulmonary diseases in the Houston area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary Diseases within 10 mi
136
Per 100K population
2.9
County median income
$73,104
Nearest hospital
MEMORIAL HERMANN - TEXAS MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Ashraf is a mixed practice specialist, with moderate Medicare volume, and low-engagement industry engagement.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Ashraf experienced with test to examine how well the lungs exchange gases?
Based on Medicare claims data, Dr. Ashraf performed 283 test to examine how well the lungs exchange gases services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ashraf receive payments from pharmaceutical companies?
Yes. Dr. Ashraf received a total of $8,933 from 37 companies across 195 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ashraf's costs compare to other pulmonary diseases in Houston?
Dr. Ashraf's average Medicare payment per service is $32. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ashraf) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →